Security key
45674E109
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB)
CUSIP: 45674E109
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 9,783,925
- Total 13F shares
- 1,208,609
- Share change
- +8,171
- Total reported value
- $2,791,095
- Price per share
- $2.31
- Number of holders
- 16
- Value change
- +$42,782
- Number of buys
- 9
- Number of sells
- 8
Report period
Q4 2022
Institutions
16
Top holders
10
INAB full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
IN8BIO, INC. SEC filings
IN8BIO, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45674E109
Recent filing periods:
Top shareholders of INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Voss Capital, LP |
13F
|
Company |
3.8%
|
375,570
|
$759,000 | — | 30 Sep 2022 | |
| Stonegate Investment Group, LLC |
13F
|
Company |
2.4%
|
232,310
|
$469,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
169,528
|
$342,000 | — | 30 Sep 2022 | |
| Sigma Planning Corp |
13F
|
Company |
1%
|
98,750
|
$199,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.76%
|
74,000
|
$149,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.72%
|
70,028
|
$141,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
52,347
|
$105,000 | — | 30 Sep 2022 | |
| PRECEPT MANAGEMENT LLC |
13F
|
Company |
0.51%
|
50,000
|
$101,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.24%
|
23,354
|
$47,000 | — | 30 Sep 2022 | |
| Warberg Asset Management LLC |
13F
|
Company |
0.15%
|
15,000
|
$30,000 | — | 30 Sep 2022 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.14%
|
14,164
|
$28,000 | — | 30 Sep 2022 | |
| United Asset Strategies, Inc. |
13F
|
Company |
0.14%
|
14,000
|
$28,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.09%
|
8,724
|
$18,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
1,821
|
$4,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
1,513
|
$3,000 | — | 30 Sep 2022 |
Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q4 2022
As of 31 Dec 2022,
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,208,609 shares.
The largest 10 holders included
Voss Capital, LLC, Stonegate Investment Group, LLC, VANGUARD GROUP INC, Sigma Planning Corp, Rock Creek Group, LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Ensign Peak Advisors, Inc, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and NORTHERN TRUST CORP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
15
Q4 2022 holders
16
Holder diff
1
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.